---
title: "Luoxin Pharmaceutical: The controlling shareholder has partially lifted the pledge of shares and re-pledged them"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263963155.md"
description: "Luoxin Pharmaceutical announced that its controlling shareholder, Luoxin Holdings, recently released the pledge of 102 million shares and pledged 101 million shares. The released pledged shares account for 43.23% of its shareholding ratio and 9.42% of the company's total share capital; the pledged shares account for 42.75% of its shareholding ratio and 9.31% of the company's total share capital. As of the announcement date, Luoxin Holdings and its concerted parties have cumulatively pledged 137 million shares, accounting for 56.83% of the shareholding ratio and 12.63% of the company's total share capital. This pledge has no substantial impact on the company"
datetime: "2025-11-03T08:13:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263963155.md)
  - [en](https://longbridge.com/en/news/263963155.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263963155.md)
---

# Luoxin Pharmaceutical: The controlling shareholder has partially lifted the pledge of shares and re-pledged them

Luoxin Pharmaceutical announced that recently its controlling shareholder, Luoxin Holdings, has partially lifted the pledge of its shares and pledged some shares. On October 31, Luoxin Holdings lifted the pledge on 102 million shares, accounting for 43.23% of its holdings and 9.42% of the company's total share capital; on the same day, Luoxin Holdings pledged 101 million shares, accounting for 42.75% of its holdings and 9.31% of the company's total share capital. As of the announcement date, Luoxin Holdings and its concerted parties have cumulatively pledged 137 million shares, accounting for 56.83% of their holdings and 12.63% of the company's total share capital. This pledge is not used to meet the operational needs of the listed company and has no substantial impact on the company

### Related Stocks

- [002793.CN](https://longbridge.com/en/quote/002793.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [ZAWYA: Emirates Islamic and FC Barcelona unite to launch exclusive co-branded card](https://longbridge.com/en/news/287034377.md)
- [US working with small biotech firm on experimental Ebola treatment, Bloomberg News reports](https://longbridge.com/en/news/287108072.md)
- [PTA-HV: Rosenbauer International AG: Voting results for the ordinary general meeting of Rosenbauer International AG on 20. May 2026](https://longbridge.com/en/news/287066674.md)
- [Singapore’s Fairprice Xtra to launch $66 all-you-can-eat durian buffet featuring Musang King, Black Thorn](https://longbridge.com/en/news/286881811.md)